Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy

Endothelial progenitor cells (EPCs) contribute to endothelial regeneration and thereby protect against cardiovascular disease (CVD). Patients with manifest CVD have reduced EPC levels, but it is not clear if this also occurs in subjects at high CVD risk without manifest atherosclerotic disease. Ther...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	European heart journal Ročník 29; číslo 22; s. 2808
Hlavní autori:	Westerweel, Peter E, Visseren, Frank L J, Hajer, Gideon R, Olijhoek, Jobien K, Hoefer, Imo E, de Bree, Petra, Rafii, Shahin, Doevendans, Pieter A, Verhaar, Marianne C
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.11.2008
Predmet:	Anticholesteremic Agents - pharmacology Azetidines - pharmacology Cross-Over Studies Drug Therapy, Combination Endothelial Cells - cytology Endothelium, Vascular - drug effects Ezetimibe Humans Male Metabolic Syndrome - complications Metabolic Syndrome - drug therapy Middle Aged Obesity - complications Postprandial Period - physiology Simvastatin - pharmacology Stem Cells - drug effects Stem Cells - physiology
ISSN:	1522-9645, 1522-9645
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!